Pediatric Hospitalizations for COVID-19 Increasing Across US States
There is significant variation across states in the rates of pediatric hospitalization for COVID-19, but the average cumulative hospitalization rate is increasing.
There is significant variation across states in the rates of pediatric hospitalization for COVID-19, but the average cumulative hospitalization rate is increasing.
Researchers evaluated obstetric complications in women with a systemic sclerosis diagnosis vs the general obstetric population.
The purpose of this study was to assess the prevalence and risk factors of new-onset glucose metabolism impairment in patients with normal fasting glycemia on long-term glucocorticoid treatment to determine which patients should undergo an oral glucose tolerance test.
The FDA is alerting patients and health care providers regarding the risk of false negatives for COVID-19 when using the Curative SARS-Cov-2 test.
The cumulative three-year incidence of osteonecrosis of the jaw is 2.8% in cancer patients receiving zoledronic acid for metastatic bone disease.
Patients already receiving opioid use disorder treatment continued to receive care during the early weeks of the COVID-19 pandemic.
In this episode, we discuss the importance of addressing mental health in the pediatric rheumatology population.
Study authors assessed the long-term effects of secukinumab on fatigue in patients with ankylosing spondylitis in the MEASURE 1 and MEASURE 2 trials.
Investigators compared differences in pain reports between patients with ankylosing spondylitis and non-radiographic axial spondyloarthritis to assess how pain sensitivity was associated with disease and health outcomes.
Researchers evaluated the safety, mechanism of action, and preliminary efficacy of rituximab and cyclophosphamide followed by belimumab in the treatment of refractory lupus nephritis.
Please login or register first to view this content.